People with albinism face significantly higher rates of skin cancer, yet access to sunscreen and dermatological care remains limited across much of the world.
In sub-Saharan Africa, a person with albinism can develop their first skin lesion before the age of ten. The sun is not an abstraction — it is a daily medical variable.
June marks Albinism Awareness Month, and this year Health-e News used the occasion to examine one of the most underdiscussed health consequences of the condition: the elevated risk of skin cancer among people with albinism, particularly in high-UV environments.
The absence of melanin means the skin has no natural barrier against ultraviolet radiation, according to Health-e News. Prolonged sun exposure without protection leads, over time, to actinic keratoses, squamous cell carcinoma, and other skin cancers at rates far exceeding those in the general population. For many people with albinism living in tropical and equatorial regions, this is not a distant risk — it is a near certainty without consistent intervention.
Sunscreen as a medical essential
Access to high-SPF sunscreen is the single most effective non-invasive protection available, Health-e News reported. Yet in many of the countries where albinism is most prevalent — including South Africa, Tanzania, and Malawi — sunscreen is classified and priced as a cosmetic product rather than a medical one. For low-income households, a tube of SPF 50 sunscreen can cost the equivalent of several days' wages.
Dermatological follow-up is equally scarce. Health-e News noted that routine skin screenings, which could catch pre-cancerous lesions early, are rarely accessible outside major urban centres. By the time many people with albinism receive a diagnosis, the cancer has already progressed.
Organisations working within the albinism community have long called for sunscreen to be reclassified as an essential medicine and distributed through public health systems, the publication reported. Some government programmes in South Africa have piloted limited sunscreen distribution, but coverage remains inconsistent and insufficient.
The month as a moment, not a solution
Awareness months generate visibility. What follows them determines whether that visibility translates into anything structural.
Health-e News framed the coverage deliberately: the skin cancer risk facing people with albinism is not a niche concern. It is a preventable health crisis concentrated among a population that already faces significant social and economic marginalisation. Early detection and consistent sun protection could reduce skin cancer mortality in this group substantially — if the systems existed to deliver them.
The conversation Albinism Awareness Month opens is useful. The question it leaves is what happens in July.
Keywords
Core topics and entities mentioned in this summary.